Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,757.50
Ask: 1,758.00
Change: 27.50 (1.59%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Miners drag as Chinese data weighs on sentiment

Mon, 10th Mar 2014 16:55

- FTSE closes down 23.22 at 6,689.45- China registers surprise trade deficit- Japan GDP revised lower- BCC increases growth forecasttechMARK 2,845.16 -0.52%FTSE 100 6,689.45 -0.35%FTSE 250 16,451.20 -0.65%It was a negative finish for the FTSE today, dragged lower by miners on the back of poor Chinese data, although gains were partially offset by a strong performance by Rolls-Royce and British American Tobacco.The top tier index closed down 23.22 points at 6,689.45.China registers surprise trade deficit, Japanese GDP revised lowerMarkets across Asia fell overnight after China's trade balance fell to a deficit of $22.98bn in February, compared with a revised surplus of $32.87bn in January and expectations for a surplus of $14.5bn. This was China's first trade deficit in 11 months and comes after exports slumped at an annual rate of 18.1%, though analysts believe this largely reflects seasonal factors such as the Chinese Lunar New Year holiday, during which many factories remained shut. Imports grew by a slightly stronger-than-forecast 10.1% during the month. Other data also showed that the annual rate of Chinese consumer price inflation fell to a 13-month low of 2% in February, down from 2.5% the month before and below forecasts.Over in Japan, revised government figures revealed that Japanese gross domestic product (GDP) expanded by just 0.7% on an annualised basis in the final three months of last year, down from the initial estimate of 1% growth. Meanwhile, the current account deficit hit a record 1.5trn yen (around £8.7bn) in January, which comes ahead of a planned tax increase on sales next month - a move that had been expected to prompt higher spending in the lead up to it.Public sector pay soars above private In UK news today, it was revealed that public sector pay has risen above private sector pay, with workers in the former paid an average 14.5% more, according to the Office of National Statistics.It said: "Average pay levels vary between the public and private sectors because of the different jobs and characteristics of the people within each sector. The average pay difference in favour of the public sector has narrowed since the year 2010, which in part reflects the restraints on public sector pay over this period."BCC predicts Q2 growth to exceed early-2008 levels The British Chambers of Commerce (BCC) has forecast an increase in the size of the UK economy that will take it above the levels seen in early 2008.It predicted economic growth for the year would be 2.8%, 0.1% higher than its previous estimate.Meanwhile, in another interesting report out today, it was claimed that although the UK economy is set to outstrip pre-recession growth levels this year, it could falter unless the country embraces immigrant workers to ease a shortage of home-grown talent.The economy, which is currently growing at about 0.7%, is set to surpass mid-2008 levels of economic growth of about 2.1% by July this year, the Business Trends report by accountants and business advisers BDO said.However, it also waded into the controversy over immigration in the UK by warning that a skills shortage could worsen unless the country becomes more positive about migrant workers.Rolls-Royce jumps on Daimler JV deal, broker commentsRolls Royce was in the top spot today after a host of analysts lifted their target prices following the engine group's move last week to buy-out Daimler in their 50-50 joint venture, Rolls-Royce Power Systems (RRPS). After the close of trade on Friday, Rolls-Royce said that it is to buy the remaining 50% stake in RRPS for £1.9bn. RRPS was formed in 2011 after Rolls-Royce and Daimler bought German engine maker Tognum.Tobacco giant British American was benefitting from comments from Citigroup, which added the stock to its 'Focus List'.GlaxoSmithKline (GSK) was also higher after it increased its stake in its pharmaceuticals subsidiary in India from 50.7% to 75% following an open offer. The transaction was valued at approximately £625m. The group said the move would increase its exposure to a "strategically important market". At the other end of the index, Persimmon was firmly in the red, most likely due to readacross from sector peer Taylor Wimpey which Numis Securities downgraded from 'add' to 'hold'. Mining stocks were also in the red as investors digested economic data from Asia. Fresnillo, Glenore Xstrata, Anglo American, Antofagasta and Rio Tinto were all trading lower by the close.Looking ahead to TuesdayTomorrow's agenda includes economic data releases on UK industrial and manufacturing production, UK gross domestic product estimates and German trade balance. Company wise, car dealership Inchcape is expected to unveil record annual results, with Numis predicting pre-tax profit of £268m, up 8.5% from £247m in 2012, driven by a strong second half. FTSE 100 - RisersRolls-Royce Holdings (RR.) 1,043.00p +1.66%British American Tobacco (BATS) 3,340.50p +1.54%Bunzl (BNZL) 1,597.00p +1.46%GlaxoSmithKline (GSK) 1,672.50p +1.15%SABMiller (SAB) 2,924.00p +1.11%United Utilities Group (UU.) 795.50p +1.08%Royal Dutch Shell 'A' (RDSA) 2,193.00p +1.01%Tate & Lyle (TATE) 642.50p +0.94%Royal Dutch Shell 'B' (RDSB) 2,342.50p +0.90%Centrica (CNA) 327.40p +0.86%FTSE 100 - FallersPersimmon (PSN) 1,329.00p -4.59%Vodafone Group (VOD) 230.10p -3.58%Petrofac Ltd. (PFC) 1,357.00p -3.42%Fresnillo (FRES) 896.00p -3.40%Pearson (PSON) 1,022.00p -3.04%WPP (WPP) 1,221.00p -2.86%Aggreko (AGK) 1,556.00p -2.75%Barclays (BARC) 242.00p -2.56%Glencore Xstrata (GLEN) 317.00p -2.42%easyJet (EZJ) 1,641.00p -2.38%FTSE 250 - RisersComputacenter (CCC) 718.50p +4.28%Partnership Assurance Group (PA.) 345.10p +3.73%COLT Group SA (COLT) 144.90p +3.50%African Barrick Gold (ABG) 308.10p +3.18%Bank of Georgia Holdings (BGEO) 2,369.00p +3.00%Pace (PIC) 458.60p +2.99%Renishaw (RSW) 2,130.00p +2.85%Pennon Group (PNN) 752.00p +2.17%Savills (SVS) 610.50p +2.00%Beazley (BEZ) 262.60p +1.74%FTSE 250 - FallersEvraz (EVR) 60.00p -5.73%Kenmare Resources (KMR) 15.27p -4.56%Barratt Developments (BDEV) 430.30p -4.02%Essar Energy (ESSR) 69.40p -3.94%Imagination Technologies Group (IMG) 166.30p -3.93%Keller Group (KLR) 1,035.00p -3.72%Bovis Homes Group (BVS) 880.50p -3.51%BlackRock World Mining Trust (BRWM) 464.80p -3.37%Greencore Group (GNC) 291.00p -3.32%Ferrexpo (FXPO) 137.00p -3.25%NR
More News
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.